WINTON GROUP Ltd grew its position in Trupanion, Inc. (NASDAQ:TRUP – Free Report) by 1.9% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 37,673 shares of the financial services provider’s stock after purchasing an additional 685 shares during the quarter. WINTON GROUP Ltd’s holdings in Trupanion were worth $1,108,000 as of its most recent filing with the SEC.
Other large investors also recently modified their holdings of the company. Sivia Capital Partners LLC bought a new stake in Trupanion during the fourth quarter valued at $31,398,000. 8 Knots Management LLC bought a new stake in shares of Trupanion during the 4th quarter valued at about $21,165,000. Wellington Management Group LLP boosted its position in shares of Trupanion by 34.6% during the 4th quarter. Wellington Management Group LLP now owns 2,453,685 shares of the financial services provider’s stock valued at $74,862,000 after purchasing an additional 630,155 shares in the last quarter. Hosking Partners LLP acquired a new stake in Trupanion during the second quarter worth approximately $3,523,000. Finally, GSA Capital Partners LLP increased its holdings in Trupanion by 376.5% in the first quarter. GSA Capital Partners LLP now owns 80,046 shares of the financial services provider’s stock worth $2,210,000 after purchasing an additional 63,247 shares in the last quarter.
Trupanion Stock Up 5.6 %
Shares of NASDAQ TRUP opened at $47.08 on Monday. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.63 and a quick ratio of 1.63. The company has a 50-day moving average price of $39.02 and a 200-day moving average price of $31.15. The stock has a market capitalization of $1.98 billion, a P/E ratio of -73.56 and a beta of 1.74. Trupanion, Inc. has a 1 year low of $19.14 and a 1 year high of $48.85.
Insider Activity at Trupanion
In related news, CFO Fawwad Qureshi sold 640 shares of the stock in a transaction on Friday, August 16th. The stock was sold at an average price of $43.12, for a total value of $27,596.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CEO Margaret Tooth sold 7,500 shares of the business’s stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total value of $348,600.00. Following the transaction, the chief executive officer now owns 99,984 shares in the company, valued at approximately $4,647,256.32. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Fawwad Qureshi sold 640 shares of the stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $43.12, for a total value of $27,596.80. The disclosure for this sale can be found here. Insiders have sold a total of 8,764 shares of company stock valued at $405,238 over the last 90 days. Insiders own 5.50% of the company’s stock.
Wall Street Analyst Weigh In
A number of research firms have issued reports on TRUP. Piper Sandler increased their price target on Trupanion from $30.00 to $38.00 and gave the stock a “neutral” rating in a report on Friday, August 9th. Evercore ISI raised shares of Trupanion to a “strong-buy” rating in a research note on Friday, August 9th. Northland Securities lifted their price target on shares of Trupanion from $30.00 to $35.00 and gave the company a “market perform” rating in a research note on Friday, August 9th. William Blair began coverage on shares of Trupanion in a research report on Friday, July 19th. They set an “outperform” rating on the stock. Finally, Stifel Nicolaus restated a “hold” rating and issued a $30.00 target price (up from $22.00) on shares of Trupanion in a research note on Friday, August 9th. Four equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, Trupanion currently has an average rating of “Moderate Buy” and a consensus target price of $36.17.
Get Our Latest Stock Analysis on TRUP
Trupanion Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Further Reading
- Five stocks we like better than Trupanion
- Why Invest in 5G? How to Invest in 5G Stocks
- Symbotic’s Double-Bagger Potential as It Hits a Key Inflection
- How Investors Can Find the Best Cheap Dividend Stocks
- High Dividend Yields Make These 2 Shipping Stocks Stand Out
- What is a Low P/E Ratio and What Does it Tell Investors?
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
Want to see what other hedge funds are holding TRUP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Trupanion, Inc. (NASDAQ:TRUP – Free Report).
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.